HTGF (High-Tech Gründerfonds)

What they fund

• Early-Stage Seed — The sweet spot for first investments is 800,000+ Euros, targeting companies not older than three years [1]., - Growth Rounds — HTGF can invest up to 30 million Euros in later financing rounds for portfolio companies [1]., - German Headquarters — Startups must have their headquarters in Germany or a German branch if based abroad [1]., - Tech Sectors — Funding is restricted to Digital Tech, Industrial, Climate & Deep Tech, Life Sciences, Chemistry, and adjacent tech areas [1].

Investment thesis

HTGF operates as a multi-stage VC platform with a founder-centric thesis: "We believe in tech. We invest in people," targeting founders building the technologies of tomorrow [1]. The firm aims to create international market leaders and strengthen Germany's technological infrastructure, positioning itself as a long-term partner from the earliest stages [1]. It leverages deep tech expertise to back sustainable solutions and complex, long-term innovations across industrial, climate, and digital tech [1].

• Founder-Centric Approach — The core belief is "We believe in tech. We invest in people," driving investments in founders building the technologies of tomorrow [1].
• Multi-Stage Platform — HTGF accompanies companies from Pre-Seed through Growth, providing capital, network, and conviction for complex, long-term innovations [1].
• Strategic Goal — The firm aims to build a "New Wirtschaftswunder" by turning German and European innovations into global tech champions [1].
• Sector Focus — Investments target Deep Tech, Life Sciences, Digital Tech, Industrial Tech, Climate Tech, and Chemistry [1].

Credibility: The thesis is directly quoted from the HTGF homepage and reinforced by the firm's stated mission to address early-stage funding gaps and foster high-tech growth [1][2].

Value add

HTGF provides capital, a network, and conviction for complex investments, acting as a long-term partner from the earliest stages [1]. The firm leverages deep tech expertise and founder experience to support companies toward international market leadership [1].

Fit verdict: Ideal for German-based deep tech founders seeking patient, multi-stage capital and a strong domestic network.

Founder diligence script:

• How does HTGF's multi-stage approach impact follow-on funding availability in later rounds?
• What specific network connections does HTGF provide for international market expansion?
• How does the firm's public-private structure influence investment decision timelines?
• What is the typical board involvement for seed-stage investments?

Portfolio focus

• Deep Tech & Climate — Proxima Fusion (nuclear fusion) and ATMOS Space Cargo (space cargo return systems) highlight the firm's focus on complex, long-term innovations [1][2]., - Life Sciences & MedTech — The portfolio includes Tubulis (antibody-drug conjugates) and Argá Medtech (cardiac catheter systems), reflecting a strong biotech presence [2]., - Digital & Industrial Tech — Companies like EGYM (digital fitness), SimScale (engineering simulations), and doinstruct (industrial learning solutions) show a broad digital/industrial reach [2]., - Circular Economy — EEDEN focuses on chemical upcycling of textile waste, aligning with the firm's climate tech and sustainability goals [2].

Notable investments & exits

• Tubulis — Acquired by Gilead for up to $5 billion, announced in April 2026 [1]., - EGYM — A digitally connected fitness solutions provider, listed as a success story [1]., - VMRay — An IT threat detection tool company, highlighted in the portfolio [2]., - SimScale — A web-based engineering simulation platform, noted as a portfolio company [2].

Strategic implications

HTGF's public-private structure provides a unique advantage in accessing stable, long-term capital, reducing pressure for quick exits. The firm's focus on deep tech and complex innovations positions it as a critical enabler of Germany's industrial and climate tech leadership. The $5 billion Tubulis exit signals HTGF's ability to back and scale biotech companies to major M&A outcomes, enhancing its reputation in life sciences.

Where they could go further

Expand international co-investment networks to better support portfolio companies in global market expansion beyond DACH., Develop more structured follow-on funding mechanisms for Series B and C to reduce reliance on external co-investors., Enhance support for commercialization and go-to-market strategies, particularly for deep tech companies with long development cycles., Increase transparency on investment decision timelines and board involvement expectations to improve founder experience.